-
Product Insights
NewNet Present Value Model: HilleVax Inc’s HIL-214
Empower your strategies with our Net Present Value Model: HilleVax Inc's HIL-214 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
HILS Dev – HILS Republica Mixed-Use Complex – Bucuresti
The HILS Dev – HILS Republica Mixed-Use Complex – Bucuresti project involves the construction of a mixed-use complex in Bucharest, Romania. Equip yourself with the essential tools needed to make informed and profitable decisions with our HILS Dev – HILS Republica Mixed-Use Complex – Bucuresti report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
NewNet Present Value Model: GSK plc’s Cobolimab
Empower your strategies with our Net Present Value Model: GSK plc's Cobolimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HIL-214 in Gastroenteritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HIL-214 in Gastroenteritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HIL-214 in GastroenteritisDrug Details:HIL-214 was under development for the prevention of acute gastroenteritis caused...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enekinragene Inzadenovec in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enekinragene Inzadenovec in Osteoarthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enekinragene Inzadenovec in Osteoarthritis Drug Details: Enekinragene inzadenovec is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-186 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TAK-186 in Pancreatic Cancer Drug Details: TAK-186 is under development for the treatment of solid...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cenobamate in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenobamate in Tonic-Clonic (Grand Mal) Seizure Drug Details: Cenobamate (Xcopri...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enekinragene Inzadenovec in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enekinragene Inzadenovec in Osteoarthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Enekinragene Inzadenovec in OsteoarthritisDrug Details: Enekinragene inzadenovec is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AG-019 in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AG-019 in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AG-019 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:AG-019 is...